PRS5 Cost-Effectiveness of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD) in the Netherlands
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI